Viewing nowJanugreen Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 202005912 · Approved 2020.08.20 · Insurance code 650304360
Improvement of glycemic control in type 2 diabetes mellitus
This drug is used to assist meal and exercise therapy to improve blood sugar control in patients with type 2 diabetes. Patients initiating treatment may use this drug alone, and if blood sugar control is insufficient with monotherapy, it can be taken in conjunction with metformin. Additionally, in cases where blood sugar control is challenging with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin, this drug can be co-administered to enhance therapeutic effects. If blood sugar control is still inadequate despite using multiple medications, this drug can be added to the treatment regimen. Thus, this drug improves blood sugar control in various situations, aiding in the management of diabetes.
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This drug may cause serious allergic reactions during use, so symptoms such as rash or difficulty breathing must be reported to healthcare professionals immediately. Serious inflammation of the pancreas (pancreatitis) may occur, so if symptoms like abdominal pain or vomiting arise, consultation with a physician is essential. This drug should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients with reduced kidney function may need to adjust the dosage of this drug, and regular kidney function testing is important. When used in conjunction with other blood sugar-lowering agents, the risk of hypoglycemia may increase, so blood sugar levels should be monitored frequently and medication dosages adjusted as necessary. If severe joint pain or skin blistering occurs, the use of this drug should be stopped immediately, and a physician should be consulted. It is not recommended for use in pregnant or breastfeeding women, and safety in children and adolescents under 18 years of age has not been established. In case of overdose, immediate hospital visit for appropriate treatment is necessary; some may be removed through hemodialysis. Regular health assessments, including liver function and blood tests, during treatment with this drug are advisable.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, joint pain associated with severe and disability, blistering dermatitis herpetiformis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased blood triglycerides, gastritis, elevated low-density lipoproteins, hyperglycemia, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
Store this drug in a tightly sealed container to prevent air or moisture from entering, and keep it at room temperature between 1 and 30 degrees Celsius. This will help maintain its effectiveness over time.
Light orange, round, biconvex film-coated tablets
30 tablets per box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.